Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

28.6%

2 terminated/withdrawn out of 7 trials

Success Rate

71.4%

-15.1% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

140%

7 of 5 completed trials have results

Key Signals

7 with results

Enrollment Performance

Analytics

Phase 2

4(57.1%)

Phase 3

2(28.6%)

Phase 1

1(14.3%)

7Total

Phase 2(4)

Phase 3(2)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT04334148Phase 3Completed

Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine

Role: lead

NCT02877095Phase 1Completed

Subcutaneous Furosemide in Acute Decompensated Heart Failure Pilot

Role: lead

NCT02742129Phase 2Completed

Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF

Role: lead

NCT03170219Phase 2Terminated

Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study

Role: lead

NCT02188784Phase 3Completed

Oral Iron Repletion Effects On Oxygen Uptake in Heart Failure

Role: lead

NCT02053493Phase 2Completed

Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction

Role: lead

NCT01954160Phase 2Terminated

Study of Renal Denervation in Patients With Heart Failure

Role: lead

All 7 trials loaded